Institute of Blood Pathology and Transfusion Medicine, Department of Hematology with Laboratory Group

Lviv 79044

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, RRMM

Studies at this site

• Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma — Completed
• A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients — Stopped early